PATENT CLAIM ANALYSIS

Application Number: 15893488
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "254090"]

Abstract:
Disclosed herein are compositions and methods for treating cancer, FLT3-AML, and CML.

Claim (Index 43):
A method of treating acute myeloid leukemia expressing a FLT3-kinase in a subject in need thereof, said method comprising administering an effective amount of a compound according to  claim 25 , thereby treating said acute myeloid leukemia.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15764724', '15796363', '15242318', '14689682', '15531245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.798669137982131
- 35 USC 102 Novelty (BERT): 0.5318411523996913
- Combined Prediction Score: 0.7719863394238871
- Mean Citation Score: 359.688486
- Max Citation Score: 364.97186
- Similarity Product: 219.47896403543828

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test